Cardinal Health Inc. Stock
Cardinal Health Inc. Stock
Cardinal Health Inc. shows a slight decrease today, losing -€1.150 (-0.660%) compared to yesterday.
The stock is an absolute favorite of our community with 21 Buy predictions and no Sell predictions.
However, we have a potential of -2.81% for Cardinal Health Inc. as the target price of 168 € is below the current price of 172.85 €.
Pros and Cons of Cardinal Health Inc. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cardinal Health Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cardinal Health Inc. | -0.660% | -1.566% | 2.339% | 45.619% | -1.901% | 142.972% | 276.908% |
| CVS Health Corp. | -0.220% | 0.921% | 0.232% | 47.268% | 1.277% | -17.333% | 10.240% |
| McKesson Corp. | 1.090% | -0.199% | 0.979% | 23.529% | -0.595% | 98.108% | 364.750% |
| AmerisourceBergen Corp. | -0.160% | -0.277% | -1.670% | 25.163% | 0.035% | 87.581% | 225.989% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01
Cardinal Health, trading under the ticker CAH, presents a complex financial picture within the Food & Drug Retailing industry. Recent financial statements indicate both positive aspects and considerable challenges. While the company showcases substantial revenue and a respectable market capitalization, it struggles with high debts and negative stockholder equity, raising concerns about its financial stability.
*Pros: *
Revenue Growth: Cardinal Health reported total revenue of approximately $205 billion for the year ending June 30, 2023. This demonstrates strong sales momentum, indicative of the company's ability to capture market demand and expand its operations in a competitive industry.
Comments
Cardinal Health (NYSE:CAH) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Show more
Ratings data for CAH provided by MarketBeat
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Leerink Partners from $211.00 to $230.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CAH provided by MarketBeat
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Argus from $189.00 to $211.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CAH provided by MarketBeat